Do you know that the average time to develop a new drug is around 10 to 12 years, costing approximately $1.2 billion when estimated conservatively? The process follows stringent protocols, competent researchers, plenty of regulatory approvals, and ethical measures to protect participants. This clinical research process plays a vital role in medical progress and the well-being of patients. Nevertheless, the entire clinical trial process is riddled with several critical pain points, despite it being for a novel cause. Not just because of complex regulations and time lags between approvals and trial activations, pharmaceutical research firms face many challenges involving patients and physicians. In this blog, we will explore the role of AI in empowering clinical trials and accelerating the quest for successful pharma research.
How can AI change the game here for clinical trials?
From pre-clinical studies to clinical trials, Artificial Intelligence (AI) can revolutionize the scene by enhancing the accuracy and efficiency of the various phases of testing, drug development, and optimizing the outcomes. Advanced AI algorithms can rapidly analyze colossal databases of chemical compounds and pinpoint the potential compounds which can bind to the target. It can also predict the toxicity of a compound and its probable side effects. As a result, scientists need not waste time on irrelevant candidates but rather focus their endeavors on promising ones.
Patient experience and insights
Regarding the patient perspective, AI can be a game changer in improving the patient experience in clinical trials. Leveraging AI in patient interactions can boost the patient experience and help reduce dropout rates. Firms can use AI algorithms to find patients, automate patient recruitment, and collect data. AI-based analysis can also provide insights into the behavior of the patients, which can provide valuable feedback on the design of the trails.
Catching the Patterns and Trends
Many pharmaceutical firms also leverage advanced AI to uncover intricate patterns within the enormous amounts of data produced by clinical trials. These patterns are immensely valuable as they unveil trends that usually go undetected via traditional methods. The real-time analysis permits researchers to detect trends and make informed decisions on trial proceedings.
Use cases of AI in clinical research.
AI algorithms can benefit drug development from clinical research by performing a broad range of tasks, including data entry, analysis, and better medical diagnosis. Following are some of the ways firms use AI in clinical trials.
Patient recruiting and screening
Manually screening and interviewing patients for clinical trials consumes enormous resources and time. On the other hand, by leveraging AI, clinical researchers can screen through large volumes of patient data and locate prospective participants based on predetermined inclusion and exclusion criteria. AI-powered chatbots and virtual assistants can gather preliminary data, answer patients’ questions, and inform them about the research. These firms can further augment patient communication with Generative AI-infused chatbots, accelerating the patient experience and encouraging them to participate.
Designing and optimizing trials
AI can identify patterns in the data and make predictions on patient behavior and drug efficacy as well. This information adds tremendous value to the researchers as they can design tailored and effective trials based on patient demographics, treatment plans, and dosages. For instance, a pharma firm can identify the ideal patient demographics by analyzing the data from earlier trials and identifying the suitable patient population who responded well to a specific treatment. Additionally, using AI tools, they can detect potential challenges, mitigate duplication, and optimize the trial further.
Data Collection and Analysis
Artificial intelligence’s capacity to autonomously gather and analyze data is one of its primary advantages. In pharmaceutical research and development, they can use the data from administrative files, health surveys, and electronic health records. This makes it possible to collect and handle data more thoroughly and accurately, producing more reliable trial findings.
Using predictive analytics, pharma companies can model how different patient groups respond to particular drugs. These insights offer baseline expectations and assist researchers in refining their products before advancing to clinical trials, thus guiding real-world trials. Furthermore, it lowers the risk of trial failure and patient injury while increasing the likelihood of success.
Detection of adverse events
Unexpected side effects, or adverse occurrences, are a crucial facet of clinical research. Conventional techniques for detecting adverse events depend on participants’ and healthcare providers’ manual reporting, which can be laborious and prone to mistakes. AI expedites this process by detecting possible adverse events more accurately and quickly than traditional methods. Machine learning algorithms can evaluate data from many sources, such as social media, patient-reported outcomes, and electronic health records. This can lessen the number of serious events, save time and improve the trial outcomes.
Intelligent Document Processing
By automating data extraction and analysis, firms can save time and resources. Not just that, Intelligent Document Processing(IDP) can find trapped data and hidden patterns that might be missed or take a much longer time to find. NLP, or Natural Language Processing, which is the bridge between human languages and computers, plays a key role here.
Benefits of leveraging AI in Clinical trials
Creating a new medicine and bringing it to market can cost millions, if not billions, of dollars. Artificial intelligence, machine learning, and other technologies can strengthen and support every facet of drug development by optimizing workflows, saving time and money, and developing cutting-edge products. Let us understand the key benefits of leveraging AI in clinical trials.
Research teams can save money and time by automating several processes crucial to clinical trials, such as safety monitoring and patient recruitment. While predictive analytics can assist enterprises in allocating resources effectively, AI can expedite critical phases such as designing clinical trials or searching for new drug compounds.
Accelerated time to market
Automation of time and labor-intensive clinical trial processes speeds up the entire process. From patient and cohort selection to data collection and analysis, AI accelerates the process by identifying potential participants for clinical trials by analyzing enormous volumes of data. Behavior analytics can also be used to identify patterns of patient behavior. AI solutions can facilitate effective internal collaboration and information access as well as prevent duplication of effort.
Improved and accurate data analysis
AI Algorithms allow researchers to swiftly examine vast volumes of data and detect patterns and trends that would be missed or take considerably longer to notice by clinical researchers.
Artificial intelligence (AI) models, for instance, can be used to forecast the toxicity of possible medication candidates, enabling research teams to eliminate substances that aren’t appropriate for additional development. The main advantage here is safety, but these AI models also help businesses avoid wasting time and resources on pointless endeavors.
Customized medicine development
Every patient has unique requirements and challenges, adding to the list of challenges in testing the treatment’s efficacy. Based on variables like genetic composition and lifestyle, AI can assist in identifying distinct patient populations that are most likely to benefit from a given medication. AI has the potential to make personalized medicine a reality.
Better patient outcomes
AI can help eliminate unpromising techniques early in the drug discovery process, thus benefiting the design of clinical trials, recruitment, and safety monitoring.
Each breakthrough in medical research expands the options available to patients in need, be it a new drug or a new use for an existing drug. Leveraging AI to analyze present drugs and treatments is a potent way to discover new uses. All in all, AI is well competent in detecting patterns in patient data and drug characteristics.
Enabling Real-Time Expertise
Instant access to current data and research is crucial in the intricate pharmaceutical realm. A unified hub for sharing past insights and engagement with subject-matter experts is essential. AI can dismantle information barriers by creating a comprehensive knowledge network, fostering teamwork, expediting innovation, and facilitating quick issue resolution. This approach grants access to experts and auto-documents their wisdom for future deployment. Improved knowledge access significantly enhances performance, as evident in R&D firms, where lacking data has caused project delays, jeopardizing patient well-being and revenue.
The power of AI looks very promising for healthcare and life sciences. Particularly, clinical research, which is very time-and-cost-consuming-key-area, can advance well from this advancement which can benefit humanity. AI, Machine Learning, data analytics, predictive analytics, and generative AI can rapidly digitize clinical trial processes and enrich them with meaningful insights into every aspect of drug development, internal processes, and patient experience. When it comes to clinical trials, the ultimate goal is the success of the trial. After all the sacrifices a patient goes through, firms should have the apt tools and technology at the right time to ensure the trial’s success. After all, clinical research is all about collecting and analyzing data for the benefit of medical sciences, and harnessing AI is the way to accelerate and augment it.
If you are looking for tailored solutions for your pharmaceutical firm or healthcare unit, check out Saxon AI offerings. We offer solutions via apps, automation, and analytics suited to your business requirements.